Last updated on 17 Jun 2022
Owner Info
Hangzhou Adlai Nortye Biopharma Co., Ltd.
Building 8, 1008 Xiangwang Street,
Yuhang District,, CHINA
Serial Number
2251522 filed on 20 Oct 2021
Correspondent
SHENZHOU HANKUN INTELLECTUAL PROPERTY AGENCY (BEIJING) CO., LTD
9/F, Office Tower C1, Oriental Plaza,,
1 East Chang An Ave.,
CHINA
2251522
20 Oct 2021
20 Oct 2031
WORD
Status Date | Action Taken |
---|---|
17th Jun 2022 | International Registration in Australia Protected correspondence sent |
16th Jun 2022 | IP Right Registration Published |
16th Jun 2022 | Status change to Registered/Protected |
9th Apr 2022 | Application Accepted correspondence sent |
8th Apr 2022 | IP Right has been Examined |
8th Apr 2022 | IP Right Acceptance Published |
8th Apr 2022 | Status change to Accepted |
1st Mar 2022 | Awaiting examination |
24th Feb 2022 | IP Right Filed Published |
24th Feb 2022 | Status change to Published |